USANA Health Sciences, Inc. (USNA) Shares Sold by Ameriprise Financial Inc.
Ameriprise Financial Inc. cut its holdings in USANA Health Sciences, Inc. (NYSE:USNA) by 2.8% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 45,928 shares of the company’s stock after selling 1,300 shares during the period. Ameriprise Financial Inc. owned 0.19% of USANA Health Sciences worth $2,650,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Northern Trust Corp lifted its holdings in USANA Health Sciences by 10.5% in the 2nd quarter. Northern Trust Corp now owns 177,630 shares of the company’s stock worth $11,386,000 after purchasing an additional 16,948 shares in the last quarter. Trust Co. of Vermont lifted its holdings in USANA Health Sciences by 482.7% in the 3rd quarter. Trust Co. of Vermont now owns 4,708 shares of the company’s stock worth $272,000 after purchasing an additional 3,900 shares in the last quarter. Schroder Investment Management Group lifted its holdings in USANA Health Sciences by 9.0% in the 2nd quarter. Schroder Investment Management Group now owns 572,186 shares of the company’s stock worth $36,734,000 after purchasing an additional 47,448 shares in the last quarter. FMR LLC lifted its holdings in USANA Health Sciences by 3.9% in the 2nd quarter. FMR LLC now owns 1,598,143 shares of the company’s stock worth $102,441,000 after purchasing an additional 60,033 shares in the last quarter. Finally, PDT Partners LLC lifted its holdings in USANA Health Sciences by 41.6% in the 2nd quarter. PDT Partners LLC now owns 24,500 shares of the company’s stock worth $1,570,000 after purchasing an additional 7,200 shares in the last quarter. 43.82% of the stock is currently owned by institutional investors.
Several analysts have recently issued reports on USNA shares. Pivotal Research upped their price objective on USANA Health Sciences from $70.00 to $80.00 and gave the stock a “buy” rating in a report on Wednesday, October 25th. BidaskClub cut USANA Health Sciences from a “hold” rating to a “sell” rating in a report on Thursday, November 2nd.
Shares of USANA Health Sciences, Inc. (NYSE:USNA) opened at $74.50 on Friday. The stock has a market capitalization of $1,800.00, a P/E ratio of 20.52 and a beta of 1.06. USANA Health Sciences, Inc. has a twelve month low of $52.55 and a twelve month high of $76.15.
USANA Health Sciences (NYSE:USNA) last issued its quarterly earnings data on Tuesday, October 24th. The company reported $1.02 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.91 by $0.11. The business had revenue of $261.77 million for the quarter, compared to analysts’ expectations of $259.52 million. USANA Health Sciences had a return on equity of 26.38% and a net margin of 8.79%. The company’s revenue for the quarter was up 3.0% on a year-over-year basis. During the same period in the prior year, the firm earned $2.40 EPS. analysts predict that USANA Health Sciences, Inc. will post 3.7 EPS for the current year.
In other news, major shareholder Global Ltd Gull sold 93,443 shares of the business’s stock in a transaction that occurred on Monday, October 30th. The stock was sold at an average price of $67.08, for a total transaction of $6,268,156.44. Following the transaction, the insider now owns 12,089,267 shares of the company’s stock, valued at approximately $810,948,030.36. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Gilbert A. Fuller sold 1,710 shares of the business’s stock in a transaction that occurred on Thursday, October 26th. The shares were sold at an average price of $67.01, for a total value of $114,587.10. Following the transaction, the director now directly owns 1,710 shares in the company, valued at approximately $114,587.10. The disclosure for this sale can be found here. Insiders have sold a total of 623,752 shares of company stock worth $41,411,372 over the last ninety days. Insiders own 53.20% of the company’s stock.
USANA Health Sciences Company Profile
USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.